AFP-TCR-T expressing a novel engineered IL-21R with constitutive IL-21 signal showed increased proliferation and tumor-infiltrating capacity, resistance to antigen-induced cell death, and superior antitumor function compared with conventional AFP-TCR-T. The gene discussed is IL21; the disease is neoplasm.